rusfertide

Twist in Protagonist story as FDA seeks to rescind breakthrough nod 'based on observed malignancies'
Fierce Biotech
Thu, 04/14/22 - 10:47 am
Protagnosit Therapeutics
rusfertide
FDA
breakthrough designation
Protagonist Therapeutics Announces Removal of FDA Clinical Hold on the Rusfertide Clinical Development Program
Yahoo Finance
Mon, 10/11/21 - 10:25 am
Protagonist Therapeutics
clinical trials
FDA
rusfertide
polycythemia